Global Blood Therapeutics Overview

Global Blood Therapeutics Gross Profit

Gross Profit analysis for GBT.

Quarterly Gross Profit

$70.14M

↑ 49.84% YoY

As of Jun 30, 2022

Annual Gross Profit (TTM)

$230.41M

↑ 42.25% YoY

Trailing 12 months ending Jun 30, 2022

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin